Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/18160
Title: Diagnostic dilemma between medication-related osteonecrosis and oral squamous cell carcinoma in a mandibular lytic lesion.
Authors: Tocaciu, S;Breik, O;Lim, B;Angel, C;Rutherford, N
Affiliation: Oral and Maxillofacial Surgery Unit, Austin Health, Heidelberg, Victoria, Australia
Department of Pathology, Peter McCallum Cancer Centre, Melbourne, Victoria
Issue Date: Nov-2017
EDate: 2017-08-26
Citation: The British journal of oral & maxillofacial surgery 2017; 55(9): e53-e57
Abstract: Osteolytic lesions of the mandible are common, and there are two important differential diagnoses that must be considered: medication-related osteonecrosis of the jaws (MRONJ) and squamous cell carcinoma (SCC). In patients with a history of taking antiresorptive medication as well as risk factors for neoplasia it can be difficult to differentiate between the two. We describe two cases in both of which a mandibular osteolytic lesion was inadequately identified as either MRONJ or SCC because of confusing clinical and histopathological features. We also reviewed relevant publications to identify similar cases. Here we discuss our clinical dilemma when faced with two different conditions that present with similar clinical and histopathological features.
URI: http://ahro.austin.org.au/austinjspui/handle/1/18160
DOI: 10.1016/j.bjoms.2017.08.005
PubMed URL: 28851496
Type: Case Reports
Journal Article
Subjects: Bisphosphonate related osteonecrosis of the jaws (BRONJ)
Medication-related osteonecrosis of the jaws (MRONJ)
Osteonecrosis
squamous cell carcinoma (SCC)
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.